Targeted Onc
@TargetedOnc
Connecting community oncology with emerging science, actionable insights & peer perspectives to advance patient care.
๊ฐ์
July 2012
3.5K ํ๋ก์ ์ค 21.1K ํฌ
At #ESMO26#, @DrDarrenFeldman (@MSKCancerCenter) discusses phase 1 data showing ixotatug vedotin drives notable responses in heavily pretreated #GermCellTumors#, with manageable ADC safety and potential phase 2 plans.
๐ฅ WATCH:
#Oncology# #CancerTreatment#
๋ ๋ณด๊ธฐ
